Association of kidney function with cancer incidence and its influence on cancer risk of smoking: The Japan Multi‐Institutional Collaborative Cohort Study
International Journal of Cancer · 2023
DOI: 10.1002/ijc.34554 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift International Journal of Cancer, 2023. Verfasst von Shimon Kurasawa und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan. Hauptthemen laut MEDLINE: Neoplasms, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
The association between kidney function and cancer incidence is inconsistent among previous reports, and data on the Japanese population are lacking. It is unknown whether kidney function modifies the cancer risk of other factors. We aimed to evaluate the association of estimated glomerular filtration rate (eGFR) with cancer incidence and mortality in 55 242 participants (median age, 57 years; 55% women) from the Japan Multi‐Institutional Collaborative Cohort Study. We also investigated differences in cancer risk factors between individuals with and without kidney dysfunction. During a median 9.3‐year follow‐up period, 4278 (7.7%) subjects developed cancer. Moderately low and high eGFRs were associated with higher cancer incidence; compared with eGFR of 60‐74 ml/min/1.73 m 2 , the adjusted hazard ratios (HRs) (95% confidence intervals [CIs]) for eGFRs of ≥90, 75‐89, 45‐59, 30‐44 and 10‐29 ml/min/1.73 m 2 were 1.18 (1.07‐1.29), 1.09 (1.01‐1.17), 0.93 (0.83‐1.04), 1.36 (1.00‐1.84) and 1.12 (0.55‐2.26), respectively. High eGFR was associated with higher cancer mortality, while low eGFR was not; the adjusted subdistribution HRs (95% CIs) for eGFRs of ≥90 and 75‐89 ml/min/1.73 m 2 were 1.58 (1.29‐1.94) and 1.27 (1.08‐1.50), respectively. Subgroup analyses of participants with eGFRs ≥60 and
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
- Department of Clinical Research Education, Nagoya University Graduate School of Medicine, Nagoya, Japan.
- Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan.
- Department of Preventive Medicine, Faculty of Medicine, Saga University, Saga, Japan.
- Department of Preventive Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
- Department of General Internal Medicine, Kyushu University Hospital, Fukuoka, Japan.
ORCID-Profile: Shimon Kurasawa, Teruhide Koyama, Keitaro Matsuo
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Kurasawa, S., Imaizumi, T., Maruyama, S., Tanaka, K., Kubo, Y., Nagayoshi, M., Ikezaki, H., Suzuki, S., Koyama, T., Koriyama, C., Kadota, A., Katsuura-Kamano, S., Kuriki, K., Wakai, K., & Matsuo, K. (2023). Association of kidney function with cancer incidence and its influence on cancer risk of smoking: The Japan Multi‐Institutional Collaborative Cohort Study. International Journal of Cancer. https://doi.org/10.1002/ijc.34554
Vancouver
Kurasawa S, Imaizumi T, Maruyama S, Tanaka K, Kubo Y, Nagayoshi M, et al. Association of kidney function with cancer incidence and its influence on cancer risk of smoking: The Japan Multi‐Institutional Collaborative Cohort Study. International Journal of Cancer. 2023. doi:10.1002/ijc.34554
BibTeX
@article{Kurasawa2023,
author = {Kurasawa, Shimon and Imaizumi, Takahiro and Maruyama, Shoichi and Tanaka, Keitaro and Kubo, Yoko and Nagayoshi, Mako and Ikezaki, Hiroaki and Suzuki, Sadao and Koyama, Teruhide and Koriyama, Chihaya and Kadota, Aya and Katsuura-Kamano, Sakurako and Kuriki, Kiyonori and Wakai, Kenji and Matsuo, Keitaro},
title = {Association of kidney function with cancer incidence and its influence on cancer risk of smoking: The Japan Multi‐Institutional Collaborative Cohort Study},
journal = {International Journal of Cancer},
year = {2023},
doi = {10.1002/ijc.34554}
}
EUVIMED